STACY BUTLER: Open Payments
NPI 1710632625 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 39 payments from 12 companies in 2025. Trend: 2023 $1,372 · 2024 $1,775 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $328 |
| GlaxoSmithKline, LLC. | 16 | $142 |
| GENZYME CORPORATION | 3 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $87 |
| CSL Behring | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $39 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $19 |
| ALK-Abello, Inc | 1 | $18 |
| BioCryst US Sales Co., LLC | 1 | $16 |
Products named: TEZSPIRE, DUPIXENT, NUCALA, CUVITRU, FASENRA, TRELEGY ELLIPTA, AIRSUPRA, Haegarda.
Industry payments across IN — which companies pay providers there.
